Home-Based Transcutaneous Bilirubin Screening and Telemedicine Reduce Neonatal Referrals
Neonatology · 2026
DOI: 10.1159/000550875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neonatology, 2026. Verfasst von Sagee Nissimov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Shamir Medical Center, Zerifin, Israel, sageen@shamir.gov.il. Hauptthemen laut MEDLINE: Referral and Consultation, Bilirubin, Neonatal Screening, Jaundice, Neonatal. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Neonatal jaundice is a leading cause of early post-discharge referrals. Community follow-up commonly relies on visual assessment and clinic-based evaluation, generating avoidable visits. Scalable home pathways that maintain safety are needed. We evaluated a nurse-led, home pathway that integrates transcutaneous bilirubin (TcB) screening with targeted pediatric teleconsultation.
Methods
Prospective before–after study within routine nurse-led home visits for eligible infants (firstborn and preterm) ≥35 weeks’ gestation. A 3-month pre-intervention phase (usual visual assessment) was compared with a 9-month intervention using TcB-guided thresholds and teleconsultation via a secure digital platform. The primary analysis targeted infants who, under usual care, would be referred (“baseline-eligible”), estimating the absolute difference in referral at the home visit. Secondary outcomes were agreement between clinical cues and TcB, teleconsultation utilization, and phototherapy requirement.
Results
1,236 infants were enrolled (157 pre-intervention; 1,079 intervention). Among baseline-eligible infants (n=840), 152 (18.1%) were referred; thus 688/840 (81.9%) potential referrals were avoided (absolute reduction 81.9%; 95% CI 79.2–84.4; NNR 1.22, 95% CI 1.19–1.26). TcB identified all infants requiring phototherapy (4/1,079; 0.4%) within 14 days. Agreement between clinical cues and TcB-defined need for follow-up was slight (weighted κ=0.075; 95% CI 0.059–0.091). The reduction in referrals corresponded to an absolute decrease of 0.67 visits per infant.
Conclusions
A nurse-led, digitally supported home pathway that integrates TcB screening and targeted teleconsultation substantially reduces unnecessary neonatal referrals, with no missed cases requiring phototherapy. This pragmatic precision-triage model is implementable within existing community services and can relieve post-discharge system burden while preserving safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Shamir Medical Center, Zerifin, Israel, sageen@shamir.gov.il.
- Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel, sageen@shamir.gov.il.
- Family Health Centers, Haifa and Western Galilee District Health Office, Public Health Services, Israeli Ministry of Health, Haifa, Israel.
- Haifa and Western Galilee District Health Office, Public Health Services, Israeli Ministry of Health, Haifa, Israel.
- Maternal Child and Adolescent Department, Public Health Directorate, Ministry of Health, Jerusalem, Israel.
- Clinical Pharmacology and Toxicology Unit, Shamir Medical Center, Zerifin, Israel.
Zitieren
APA
Nissimov, S., Haas, N., Habib, S., Madjar, B., Zimmerman, D. R., Hazan, A., Daniel, S., Berkovitch, M., & Kohn, E. (2026). Home-Based Transcutaneous Bilirubin Screening and Telemedicine Reduce Neonatal Referrals. Neonatology. https://doi.org/10.1159/000550875
Vancouver
Nissimov S, Haas N, Habib S, Madjar B, Zimmerman DR, Hazan A, et al. Home-Based Transcutaneous Bilirubin Screening and Telemedicine Reduce Neonatal Referrals. Neonatology. 2026. doi:10.1159/000550875
BibTeX
@article{Nissimov2026,
author = {Nissimov, Sagee and Haas, Nili and Habib, Sonia and Madjar, Batia and Zimmerman, Deena R and Hazan, Ariela and Daniel, Sharon and Berkovitch, Matitiahu and Kohn, Elkana},
title = {Home-Based Transcutaneous Bilirubin Screening and Telemedicine Reduce Neonatal Referrals},
journal = {Neonatology},
year = {2026},
doi = {10.1159/000550875}
}
EUVIMED